Actinogen Medical Eyes Future With New Options

Actinogen Medical Limited (AU:ACW) has released an update.

Actinogen Medical Limited has applied for quotation of a new class of listed options on the ASX, which will expire on September 30, 2027. A total of 174,375,001 of these options will be issued at $0.05 each on September 24, 2024. This move represents an opportunity for investors to engage with the company’s future on the stock market.

For further insights into AU:ACW stock, check out TipRanks’ Stock Analysis page.